{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/8792"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/8792","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"EFFECTS OF [symbol removed]3-POLYUNSATURATED FATTY ACIDS ON TIlE FORMATION OF sn-1,2-DIRADYLGLYCEROL, CYTOKINE SECRETION AND THE REGULATION OF PROTEIN KINASE C ACTIVITY","abstract":"<p>The focus of my thesis was to investigate changes in the formation of<br />second messenger sn-1,2-diradylglycerol (DG) and phospholipids (PL) in murine<br />peritoneal macrophages in vitro and in vivo in response to varying concentrations<br />of the 3-olyunsaturated fatty acids ([symbol removed]3PUFA), eicosapentaenoic (EPA, 20:5[symbol removed]3) and docosahexaenoic (DHA, 22:6[symbol removed]3) acids. My findings establish for the first time that the incorporation of EPA and DHA into DG and membrane PL occurs<br />independently and dose-dependently, with EPA being incorporated to a greater<br />extent than DHA.</p> <p>It was of interest to investigate the functional correlations of the substitution<br />of [symbol removed]3PUFA into DG and PL molecular species. DG is classically known as the physiological activator of protein kinase C (PKC). I investigated the effects on<br />PKC activation by pure species of diacylglycerol (DAG) with oleoyl, arachidonoyl,<br />eicosapentaenoyl or docosahexaenoyl at the sn-2 position. These results showed<br />that DG species with DHA or EPA incorporated at the sn-2 position activate PKC.<br />However, while DG with DHA at the sn-2 position activated PKC to a similar<br />extent as did DG with AA at the sn-2 position (representative of physiological DG),<br />DG with EPA at the sn-2 position activated PKC to a significantly lesser degree.<br />To the best of my knowledge, this is the first demonstration in the literature that the activation of PKC in vitro differs significantly among these molecular species<br />of DAG.</p> <p>The immunoregulatory cytokine, interleukin-6 (IL-6), is produced in<br />response to tissue injury and inflammation and in vitro by LPS-stimulated<br />macrophages. I investigated the correlation of [symbol removed]3PUFA substitution into DC and<br />secretion of IL-6 by LPS-stimulated murine peritoneal macrophages. These results<br />show for the first time that IL-6 secretion is attenuated by [symbol removed]3PUFA, and to a<br />greater extent by DHA than by EPA.</p> <p>I have obtained several novel findings that contribute to improved<br />understanding of the underlying mechanisms by which [symbol removed]3PUFA function at the<br />level of signal transduction. The ability to modify the fatty acid composition of the<br />signalling molecule, DG, with [symbol removed]3PUFA can now be used for future research to<br />further elucidate the functional ramifications of [symbol removed]3PUFA in cell signal<br />transduction.</p>","abstract_html":"&lt;p&gt;The focus of my thesis was to investigate changes in the formation of&lt;br /&gt;second messenger sn-1,2-diradylglycerol (DG) and phospholipids (PL) in murine&lt;br /&gt;peritoneal macrophages in vitro and in vivo in response to varying concentrations&lt;br /&gt;of the 3-olyunsaturated fatty acids ([symbol removed]3PUFA), eicosapentaenoic (EPA, 20:5[symbol removed]3) and docosahexaenoic (DHA, 22:6[symbol removed]3) acids. My findings establish for the first time that the incorporation of EPA and DHA into DG and membrane PL occurs&lt;br /&gt;independently and dose-dependently, with EPA being incorporated to a greater&lt;br /&gt;extent than DHA.&lt;/p&gt; &lt;p&gt;It was of interest to investigate the functional correlations of the substitution&lt;br /&gt;of [symbol removed]3PUFA into DG and PL molecular species. DG is classically known as the physiological activator of protein kinase C (PKC). I investigated the effects on&lt;br /&gt;PKC activation by pure species of diacylglycerol (DAG) with oleoyl, arachidonoyl,&lt;br /&gt;eicosapentaenoyl or docosahexaenoyl at the sn-2 position. These results showed&lt;br /&gt;that DG species with DHA or EPA incorporated at the sn-2 position activate PKC.&lt;br /&gt;However, while DG with DHA at the sn-2 position activated PKC to a similar&lt;br /&gt;extent as did DG with AA at the sn-2 position (representative of physiological DG),&lt;br /&gt;DG with EPA at the sn-2 position activated PKC to a significantly lesser degree.&lt;br /&gt;To the best of my knowledge, this is the first demonstration in the literature that the activation of PKC in vitro differs significantly among these molecular species&lt;br /&gt;of DAG.&lt;/p&gt; &lt;p&gt;The immunoregulatory cytokine, interleukin-6 (IL-6), is produced in&lt;br /&gt;response to tissue injury and inflammation and in vitro by LPS-stimulated&lt;br /&gt;macrophages. I investigated the correlation of [symbol removed]3PUFA substitution into DC and&lt;br /&gt;secretion of IL-6 by LPS-stimulated murine peritoneal macrophages. These results&lt;br /&gt;show for the first time that IL-6 secretion is attenuated by [symbol removed]3PUFA, and to a&lt;br /&gt;greater extent by DHA than by EPA.&lt;/p&gt; &lt;p&gt;I have obtained several novel findings that contribute to improved&lt;br /&gt;understanding of the underlying mechanisms by which [symbol removed]3PUFA function at the&lt;br /&gt;level of signal transduction. The ability to modify the fatty acid composition of the&lt;br /&gt;signalling molecule, DG, with [symbol removed]3PUFA can now be used for future research to&lt;br /&gt;further elucidate the functional ramifications of [symbol removed]3PUFA in cell signal&lt;br /&gt;transduction.&lt;/p&gt;","abstract_has_math":false,"creators":["Marignani, Paola A."],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Medical Sciences","school":null,"contributors":[],"advisors":["Sebaldt, Rolf J."],"committee_chairs":[],"committee_members":[],"year":1996,"date_issued":"1996-08","date_published":"1996-08","updated_at":"2026-11-18T19:38:56Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/22346"],"render_values":[{"text":"https://doi.org/10.71548/22346","href":"https://doi.org/10.71548/22346","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/3967","4984","1876006"],"render_values":[{"text":"opendissertations/3967","href":null,"code":true},{"text":"4984","href":null,"code":true},{"text":"1876006","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/8792","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/8792","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F8792","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Sebaldt, Rolf J."]},{"key":"dc:contributor.department","label":"Department","values":["Medical Sciences"]},{"key":"dc:creator","label":"Author","values":["Marignani, Paola A."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-06-18T16:44:00Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-06-18T16:44:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2011-03-15"]},{"key":"dc:date.issued","label":"Date","values":["1996-08"]},{"key":"dc:type","label":"Dc Type","values":["thesis"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/3967","4984","1876006"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/8792","https://doi.org/10.71548/22346"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>The focus of my thesis was to investigate changes in the formation of<br />second messenger sn-1,2-diradylglycerol (DG) and phospholipids (PL) in murine<br />peritoneal macrophages in vitro and in vivo in response to varying concentrations<br />of the 3-olyunsaturated fatty acids ([symbol removed]3PUFA), eicosapentaenoic (EPA, 20:5[symbol removed]3) and docosahexaenoic (DHA, 22:6[symbol removed]3) acids. My findings establish for the first time that the incorporation of EPA and DHA into DG and membrane PL occurs<br />independently and dose-dependently, with EPA being incorporated to a greater<br />extent than DHA.</p> <p>It was of interest to investigate the functional correlations of the substitution<br />of [symbol removed]3PUFA into DG and PL molecular species. DG is classically known as the physiological activator of protein kinase C (PKC). I investigated the effects on<br />PKC activation by pure species of diacylglycerol (DAG) with oleoyl, arachidonoyl,<br />eicosapentaenoyl or docosahexaenoyl at the sn-2 position. These results showed<br />that DG species with DHA or EPA incorporated at the sn-2 position activate PKC.<br />However, while DG with DHA at the sn-2 position activated PKC to a similar<br />extent as did DG with AA at the sn-2 position (representative of physiological DG),<br />DG with EPA at the sn-2 position activated PKC to a significantly lesser degree.<br />To the best of my knowledge, this is the first demonstration in the literature that the activation of PKC in vitro differs significantly among these molecular species<br />of DAG.</p> <p>The immunoregulatory cytokine, interleukin-6 (IL-6), is produced in<br />response to tissue injury and inflammation and in vitro by LPS-stimulated<br />macrophages. I investigated the correlation of [symbol removed]3PUFA substitution into DC and<br />secretion of IL-6 by LPS-stimulated murine peritoneal macrophages. These results<br />show for the first time that IL-6 secretion is attenuated by [symbol removed]3PUFA, and to a<br />greater extent by DHA than by EPA.</p> <p>I have obtained several novel findings that contribute to improved<br />understanding of the underlying mechanisms by which [symbol removed]3PUFA function at the<br />level of signal transduction. The ability to modify the fatty acid composition of the<br />signalling molecule, DG, with [symbol removed]3PUFA can now be used for future research to<br />further elucidate the functional ramifications of [symbol removed]3PUFA in cell signal<br />transduction.</p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Doctor of Philosophy (PhD)"]},{"key":"dc:title","label":"Title","values":["EFFECTS OF [symbol removed]3-POLYUNSATURATED FATTY ACIDS ON TIlE FORMATION OF sn-1,2-DIRADYLGLYCEROL, CYTOKINE SECRETION AND THE REGULATION OF PROTEIN KINASE C ACTIVITY"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Sebaldt, Rolf J."],"dc:contributor.department":["Medical Sciences"],"dc:creator":["Marignani, Paola A."],"dc:date.accessioned":["2014-06-18T16:44:00Z"],"dc:date.available":["2014-06-18T16:44:00Z"],"dc:date.created":["2011-03-15"],"dc:date.issued":["1996-08"],"dc:description.abstract":["<p>The focus of my thesis was to investigate changes in the formation of<br />second messenger sn-1,2-diradylglycerol (DG) and phospholipids (PL) in murine<br />peritoneal macrophages in vitro and in vivo in response to varying concentrations<br />of the 3-olyunsaturated fatty acids ([symbol removed]3PUFA), eicosapentaenoic (EPA, 20:5[symbol removed]3) and docosahexaenoic (DHA, 22:6[symbol removed]3) acids. My findings establish for the first time that the incorporation of EPA and DHA into DG and membrane PL occurs<br />independently and dose-dependently, with EPA being incorporated to a greater<br />extent than DHA.</p> <p>It was of interest to investigate the functional correlations of the substitution<br />of [symbol removed]3PUFA into DG and PL molecular species. DG is classically known as the physiological activator of protein kinase C (PKC). I investigated the effects on<br />PKC activation by pure species of diacylglycerol (DAG) with oleoyl, arachidonoyl,<br />eicosapentaenoyl or docosahexaenoyl at the sn-2 position. These results showed<br />that DG species with DHA or EPA incorporated at the sn-2 position activate PKC.<br />However, while DG with DHA at the sn-2 position activated PKC to a similar<br />extent as did DG with AA at the sn-2 position (representative of physiological DG),<br />DG with EPA at the sn-2 position activated PKC to a significantly lesser degree.<br />To the best of my knowledge, this is the first demonstration in the literature that the activation of PKC in vitro differs significantly among these molecular species<br />of DAG.</p> <p>The immunoregulatory cytokine, interleukin-6 (IL-6), is produced in<br />response to tissue injury and inflammation and in vitro by LPS-stimulated<br />macrophages. I investigated the correlation of [symbol removed]3PUFA substitution into DC and<br />secretion of IL-6 by LPS-stimulated murine peritoneal macrophages. These results<br />show for the first time that IL-6 secretion is attenuated by [symbol removed]3PUFA, and to a<br />greater extent by DHA than by EPA.</p> <p>I have obtained several novel findings that contribute to improved<br />understanding of the underlying mechanisms by which [symbol removed]3PUFA function at the<br />level of signal transduction. The ability to modify the fatty acid composition of the<br />signalling molecule, DG, with [symbol removed]3PUFA can now be used for future research to<br />further elucidate the functional ramifications of [symbol removed]3PUFA in cell signal<br />transduction.</p>"],"dc:description.degree":["Doctor of Philosophy (PhD)"],"dc:identifier.other":["opendissertations/3967","4984","1876006"],"dc:identifier.uri":["http://hdl.handle.net/11375/8792","https://doi.org/10.71548/22346"],"dc:title":["EFFECTS OF [symbol removed]3-POLYUNSATURATED FATTY ACIDS ON TIlE FORMATION OF sn-1,2-DIRADYLGLYCEROL, CYTOKINE SECRETION AND THE REGULATION OF PROTEIN KINASE C ACTIVITY"],"dc:type":["thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:38:56Z"}